160 related articles for article (PubMed ID: 2515678)
1. [Antitubercular agents. 45. Antimycobacterial thiohydrazide].
Waisser K; Odlerová Z; Houngbedji N; Thiel W; Mayer R
Zentralbl Mikrobiol; 1989; 144(5):355-7. PubMed ID: 2515678
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antimycobacterial activity of a new quinolone, T-3761].
Tomioka H; Sato K; Saito H
Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
[TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y
Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
Cavicchioli M; Leite CQ; Sato DN; Massabni AC
Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
[TBL] [Abstract][Full Text] [Related]
6. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium resistance to antimycobacterial reagent.
Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs].
Zhao T; Yang SR
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058
[No Abstract] [Full Text] [Related]
9. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
Truffot-Pernot C; Giroir AM; Maury L; Grosset J
Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
[TBL] [Abstract][Full Text] [Related]
11. [Antitubercular agents. 49. Thiohydrazides, potential antitubercular agents].
Waisser K; Houngbedji N; Odlerová Z; Thiel W; Mayer R
Pharmazie; 1990 Feb; 45(2):141-2. PubMed ID: 2111032
[No Abstract] [Full Text] [Related]
12. Synthesis and antimycobacterial activity of some new 3-heterocyclic substituted chromones.
Gasparová R; Lácová M; el-Shaaer HM; Odlerová Z
Farmaco; 1997 Apr; 52(4):251-3. PubMed ID: 9241831
[TBL] [Abstract][Full Text] [Related]
13. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M
J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459
[TBL] [Abstract][Full Text] [Related]
14. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?
Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224
[TBL] [Abstract][Full Text] [Related]
15. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
Yamamoto S; Toida I; Watanabe N; Ura T
Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
[TBL] [Abstract][Full Text] [Related]
16. [New active drugs against the tuberculosis bacillus and other mycobacteria].
de Kantor IN
Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
[No Abstract] [Full Text] [Related]
17. [Azabischalcones--a new class of potential antitubercular agents].
Kozmík V; Lhoták P; Odlerová Z; Palecek J
Ceska Slov Farm; 1998 Mar; 47(2):87-90. PubMed ID: 9650367
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of Mycobacteria from patients with genital tuberculosis].
Blagodarnyĭ IaA; Alimbekova OA; Blonskaia LI
Probl Tuberk; 1990; (1):37-41. PubMed ID: 2110667
[TBL] [Abstract][Full Text] [Related]
19. [Resistance to antitubercular drugs of atypical Mycobacterium pathogenic to man].
Casal Román M
Rev Clin Esp; 1978 Feb; 148(4):343-5. PubMed ID: 653055
[No Abstract] [Full Text] [Related]
20. Isolation, identification and drug sensitivity pattern of mycobacterial strains isolated from human patients.
Nain PS; Chandiramani NK; Darg DN
Indian J Pathol Microbiol; 1987 Jul; 30(3):261-6. PubMed ID: 3130312
[No Abstract] [Full Text] [Related]
[Next] [New Search]